LPA acts on insulin receptors or their downstream signaling pathways, inhibiting insulin sensitivity, thereby aggravating insulin resistance, which may lead to reduced utilization of glucose by retinal tissue and aggravate retinal ischemia and hypoxia (22, 23). The gene discussed is INSR; the disease is Insulin resistance.